Evidence map›Paper›PMID 36606710›Full record

ArticleACS chemical biology2023

Optimization of PROTAC Ternary Complex Using DNA Encoded Library Approach.

Qiuxia Chen, Chuan Liu, Wei Wang, Xiaoyun Meng, Xuemin Cheng, Xianyang Li, Longying Cai, Linfu Luo, Xu He, Huan Qu and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in ACS chemical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Methods to accelerate PROTAC drug discovery.The Biochemical journal · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Building Block-Centric Approach to DNA-Encoded Library Design.Journal of chemical information and modeling · 2024
    Article
  13. Article
  14. Affinity for both sides.Nature chemical biology · 2024
    Article
  15. Article
  16. Article
  17. Small-molecule discovery through DNA-encoded libraries.Nature reviews. Drug discovery · 2023
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Qiuxia Chen
Chuan Liu
Wei Wang
Xiaoyun Meng
Xuemin Cheng
Xianyang Li
Longying Cai
Linfu Luo
Xu He
Huan Qu
Jing Luo
Hong Wei
Sen Gao
Jinqiao Wan
David I IsraelHitGen Inc., Chengdu, Sichuan 610200, China.
Jin LiHitGen Inc., Chengdu, Sichuan 610200, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The proteolysis targeting chimera (PROTAC) strategy results in the down-regulation of unwanted protein(s) for disease treatment. In the PROTAC process, a heterobifunctional degrader forms a ternary complex with a target protein of interest (POI) and an E3 ligase, which results in ubiquitination and proteasomal degradation of the POI. While ternary complex formation is a key attribute of PROTAC degraders, modification of the PROTAC molecule to optimize ternary complex formation and protein degradation can be a labor-intensive and tedious process. In this study, we take advantage of DNA-encoded library (DEL) technology to efficiently synthesize a vast number of possible PROTAC molecules and describe a parallel screening approach that utilizes DNA barcodes as reporters of ternary complex formation and cooperative binding. We use a designed PROTAC DEL against BRD4 and CRBN to describe a dual protein affinity selection method and the direct discovery of novel, potent BRD4 PROTACs that importantly demonstrate clear SAR. Such an approach evaluates all the potential PROTACs simultaneously, avoids the interference of PROTAC solubility and permeability, and uses POI and E3 ligase proteins in an efficient manner.

Indexed as

Nuclear ProteinsTranscription FactorsProteolysisUbiquitinationUbiquitin-Protein LigasesNuclear ProteinsTranscription FactorsUbiquitin-Protein Ligases

Identifiers

PMID36606710
PMCPMC9872815
OpenAlexW4313645693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.